With Biocon Biologics since 2022, Matthew Erick drives commercial strategy and sales in the advanced markets of North America, Europe, Japan, Australia and New Zealand. Matt works closely with partners in these markets to promote Biocon Biologics’ product portfolio and also leads the ‘go to market’ strategy for the company.
Matt has over two decades of experience in the pharmaceuticals and healthcare industry in the US, with a demonstrated track record of strategic planning, driving business growth and profitability, leading commercial operations, managing large teams and developing a collaborative work culture.
Before joining Biocon Biologics, he held various commercial and executive leadership roles at MedVet, Viatris, Cardinal Health in the US. Matt also worked with Mylan (Viatris) for 10 years, leading Sales and Marketing as President – North America. He worked in various roles at Cardinal Health and also led MedVet, a specialty veterinary hospital chain, as their President.
Matt holds Bachelor’s degrees in both Pharmacy and Biology.
